Proteome Sciences reports "potential breakthrough" in Alzheimer's blood test; but still some way to go
This article was originally published in Clinica
Executive Summary
UK diagnostics firm Proteome Sciences has reported positive preliminary results from a 1,000-patient study of protein biomarkers for Alzheimer's disease, raising hopes of a blood test for the disorder. The company is not releasing detailed results from the study, but concluded that its markers have "significant potential diagnostic and prognostic utility".